GlaxoSmithKline boss says new drugs can be cheaper
LONDON (Reuters) - The pharmaceutical industry should be able to charge less for new drugs in future by passing on efficiencies in research and development to its customers, according to the chief executive of GlaxoSmithKline Plc. "It's not unrealisti...